Filing Flows › Diversified Healthcare Trust (DHC) › Stock forecast & fair value
Diversified Healthcare Trust (DHC) stock forecast and fair value
Diversified Healthcare Trust (DHC) trades at $7.02. 4 analysts' median price target is $10.55 (+50%), from $8.00 to $11.50. Across 13 valuation methods the middle fair value is $7.01 (-0.2%).
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| EV/Sales vs peers | $16.53 | $44.44 | $60.57 | +533% |
| EV/Sales vs peers, weighted | $43.77 | $62.42 | $76.25 | +789% |
| EV/Sales vs peers, matched | $12.39 | $44.44 | $57.99 | +533% |
| Residual income | $2.81 | $2.93 | $3.05 | -58% |
| P/FFO vs REIT peers | $4.60 | $5.44 | $7.85 | -22% |
| P/FFO vs REIT peers, weighted | $5.42 | $7.01 | $10.00 | -0.2% |
| Analysts' price targets | $8.00 | $10.15 | $11.50 | +45% |
| Shareholder yield (dividends + buybacks) | $0.83 | $1.02 | $1.31 | -85% |
| Dividend discount (Gordon) | $0.75 | $0.91 | $1.17 | -87% |
| Stage-weighted value (reit) | $3.38 | $3.91 | $5.31 | -44% |
Diversified Healthcare Trust's latest quarter
Diversified Healthcare Trust, Q3 2026: revenue $368M (-5% year over year), operating margin -4.0%, net loss $50.2M, operating cash flow $27.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for DHC stock?
The median of 4 analysts' 12-month targets is $10.55, +50% from $7.02; the range is $8.00 to $11.50. The average rating is buy.
What is Diversified Healthcare Trust's fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $0.80 and $62.42, with a middle value of $7.01 against a price of $7.02. Each method's assumptions are on the page.
Does Diversified Healthcare Trust usually beat earnings estimates?
It beat the consensus EPS estimate in 80% of the quarters on record.
Is DHC stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.